Oruka Therapeutics, Stock Today
| ORKA Stock | 11.63 0.16 1.39% |
PerformanceVery Weak
| Odds Of DistressLow
|
Oruka Therapeutics, is trading at 11.63 as of the 20th of March 2025, a 1.39% up since the beginning of the trading day. The stock's open price was 11.47. Oruka Therapeutics, has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days.Oruka Therapeutics, symbol was changed from ABIO on 3rd of September 2024. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Moving together with Oruka Stock
Moving against Oruka Stock
Oruka Stock Highlights
| Older Symbol | ABIO |
| CEO President | Lawrence Klein |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Oruka Therapeutics, (ORKA) is traded on NASDAQ Exchange in USA. It is located in Building 23, Waltham, MA, United States, 02453 and employs 28 people. Oruka Therapeutics, was previously known as ABIO Old and was traded on NASDAQ Exchange under the symbol ABIO. Oruka Therapeutics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 888.26 M. Oruka Therapeutics, conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1000 K outstanding shares of which 1.76 M shares are now shorted by private and institutional investors with about 0.0 trading days to cover.
Check Oruka Therapeutics, Probability Of Bankruptcy
Oruka Therapeutics, Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Oruka Therapeutics, market risk premium is the additional return an investor will receive from holding Oruka Therapeutics, long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.83) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | 2.68 |
Oruka Stock Against Markets
Oruka Therapeutics, Corporate Management
| Paul Quinlan | General Secretary | Profile | |
| Joana MD | Chief Officer | Profile | |
| Arjun CPA | Senior Treasurer | Profile | |
| Rajiv Panwar | Manufacturing Chemistry | Profile | |
| Christopher Finch | Vice Strategy | Profile | |
| Joe Senn | Senior Development | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oruka Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics,. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics, is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics,'s market value can be influenced by many factors that don't directly affect Oruka Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.